-
Colonization of methicillin-resistant Staphylococcus aureus (MRSA) in the groin area of HIV-infected adults increases risk for subsequent clinical infection, according to results of a prospective study carried out by the Centers for Disease Control and Prevention.
14 March 2013 | Medscape (requires registration)
-
One lot of cidofovir for intravenous infusion (Vistide), used to treat cytomegalovirus (CMV) retinitis in AIDS patients, has been recalled because of particulate matter in some vials, the FDA said.
19 February 2013 | MedPage Today HIV/AIDS
-
A metanalysis of cohort and case control studies finds that current smokers with HIV were at double the risk of bacterial pneumonia than non-smoking counterparts, but that when people stopped smoking their risk was reduced.
22 January 2013 | Science Daily (press release)
-
HIV positive people who received a quadruple dose of a trivalent seasonal influenza vaccine produced more protective antibodies without a significant increase in side effects, researchers reported in the January 1, 2013, Annals of Internal Medicine.
04 January 2013 | HIVandHepatitis.com
-
A new study by NYU School of Medicine researchers suggests that an existing HIV drug called maraviroc could be a potential therapy for Staphylococcus aureus, a notorious and deadly pathogen linked to hundreds of thousands of hospitalizations each year. Their study is published online this week in Nature.
17 December 2012 | NYU Langone Medical Center
-
The word "herpes" conjures negative stereotypes, but most people are infected with some form of the virus. After a flare-up, the virus usually remains latent until the right circumstances to return. Now, research in the Journal of Leukocyte Biology sheds some light on what triggers the virus to reactivate. It shows that the immune system may actually lose control over the virus when facing new microbial threats, such as fending off other viruses or bacteria.
01 November 2012 | Eurekalert Inf Dis
-
People living with HIV should receive two different vaccines to help prevent serious strep-related illness.
19 October 2012 | AIDSMeds
-
Immunocompromised individuals, including people with HIV, should receive both the 13-valent pneumococcal conjugate vaccine Prevnar 13 and the 23-valent pneumococcal polysaccharide vaccine Pneumovax 23 to prevent pneumococcal pneumonia and invasive disease, according to the latest recommendations from the Centers for Disease Control and Prevention (CDC).
18 October 2012 | HIVandhepatitis.com
-
New York City HIV-positive men who have had intimate contact with other men under certain circumstances since the beginning of September 2012 should receive the meningococcal vaccine, according to a new recommendation from the NYC Department of Health and Mental Hygiene.
08 October 2012 | AIDSMeds
-
A nastier kind of salmonella infection has emerged alongside the HIV epidemic in Africa. The finding is the first evidence that HIV might be allowing new human pathogens to evolve in immunosuppressed people.
02 October 2012 | New Scientist
Get set for HIV treatmentA tool to help you decide whether you are ready to start taking HIV treatment.
HIV, GPs & other primary careThis booklet explains the services GPs offer, how this fits with HIV specialist care, and how to make the most of primary care services.
Treatment as prevention – free webinar 20 March 2013As
part of its European HIV prevention work, NAM is collaborating...
Microbicides research – free webinar 22 February 2013As
part of its European HIV prevention work, NAM is collaborating...
HIV treatment update – Winter 2013 21 February 2013The new edition of HIV treatment update (HTU) is on...